Risperidone-induced priapism in an autistic child: a case report by unknown
CASE REPORT Open Access
Risperidone-induced priapism in an autistic
child: a case report
Bouchra Aabbassi*, Abdeslam Benali and Fatima Asri
Abstract
Background: Priapism is a prolonged stimulation with painful, persistent penile erection unaccompanied by sexual
desire. It is a rare but serious urological emergency. Risperidone is an atypical antipsychotic widely prescribed for
the treatment of behavior problems in children with autism spectrum disorder. It seems associated with priapism
in children.
Case presentation: We present a case of a 12-year-old Moroccan boy diagnosed with autism spectrum disorder
who developed priapism while on an existing regimen of risperidone, and we report the treatment decisions that
followed.
Conclusions: Clinicians who prescribe risperidone should be aware of the possibility of this rare complication in
their patients. Information about this possible side effect and instructions regarding appropriate response should be
made available to caregivers of those in the at-risk group of young patients.
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Background
Priapism is a prolonged stimulation with painful, persist-
ent penile erection unaccompanied by sexual desire. Pri-
apism is a relatively rare condition; however, due to this
potentially serious and long-term consequences and its
potential as an adverse effect of many common medica-
tions, it is a matter of serious concern for clinicians. We
present a case of an autistic child who developed priap-
ism while on an existing regimen of risperidone, and we
report the treatment decisions that followed.
Case presentation
Our patient was a 12-year-old Moroccan boy diagnosed
with autism spectrum disorder. In early childhood, he
was unable to develop speech; he only screamed sharply
if in distress or in need of attention. He avoided eye con-
tact, and he often appeared to be looking into space, fo-
cusing on an unseen object. He had behavior problems,
including hitting, kicking, and biting. He rarely played
with other children, and he was unable to acquire new
skills. He had no history of any major medical illness
that could influence normal neurological development
during childhood. Upon presentation to our clinic at 10
years of age, the boy could not utter a word, but only
shouted and screamed. He had not been exposed to any
form of schooling and appeared distant when attempts
were made to interact with him. The child met the cri-
teria of the Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition, for a diagnosis of autism
spectrum disorder.
At the age of 12 years, the boy’s associated behavior
problems included destructive tendencies, screaming
without apparent reason, aggression, self-injury, and ir-
ritability. Risperidone was prescribed to manage these
disruptive behavior symptoms. The dosage was increased
gradually to 2 mg/day to control the boy’s behavior
problems. After taking the medication, the child awoke
with a painful erection that lasted 6 h. He had no history
of penile, genital, or pelvic trauma, and he had no evi-
dence of any infection or malignancy. He had no change
in his current medications and no reported use of any
medication or any herbal preparation.
He was immediately sent to the emergency depart-
ment. Laboratory tests were performed, including a
complete blood count, a basic metabolic profile, and a
coagulation study. All the results were within normal
limits. Discontinuation of risperidone led to an
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improvement in the boy’s pain. The urology service was
consulted, and the boy’s priapism resolved completely
within a few hours after intracavernosal washing. Risper-
idone was the only known causative factor, and it was
discontinued. On leaving the hospital, a prescription of
antipsychotic treatment was indicated. We prescribed
aripiprazole; however, the boy’s family did not have the
financial means to procure this expensive medication.
Instead, the boy was treated with 150 mg/day of sulpir-
ide safely with a favorable outcome. The boy’s priapism
had not returned when he was seen in follow-up 4
months later. In this patient, we established a probable
causal relationship between risperidone and priapism
using the Naranjo Adverse Drug Reaction Probability
Scale, on which the patient’s score was 7 [1].
Discussion
Priapism can occur in all age groups. The pathophysiology
is still unclear, and it is considered to be multifactorial in
origin [2]. Some common etiological factors in children in-
clude leukemia, spinal and perineal trauma, sickle cell
anemia, thrombocytopenia, malignancy, neurological disor-
ders, and the use of certain drugs [2, 3]. Antipsychotic
agents are implicated in 15–26 % of cases of priapism asso-
ciated with medications [3]. Among atypical antipsychotics,
clozapine, risperidone, and olanzapine have been reported
to be associated with the condition as well [2–4]. Recent
evidence indicates that atypical antipsychotics represent a
promising option for the treatment of autism spectrum dis-
order [2, 3]. In particular, risperidone appears to be effective
in treating aggressiveness, hyperactivity, irritability, stereoty-
pies, social withdrawal, and lack of interests [5]. However,
risperidone can have side effects that suggest an informal
analysis of the medication’s use. Much has been discussed
about the metabolic side effects; however, relatively little is
known about the occurrence of ischemic priapism, which
has been reported with risperidone in a few cases in differ-
ent countries [3, 4, 6, 7].
Ischemic priapism accounts for 95 % of cases of priapism
[2]. It is caused by obstruction of the venous drainage from
the corpora cavernosa of the penis. Although the relation-
ship between psychotropic medication and priapism is well
documented, the exact incidence is unknown. The pro-
posed mechanism responsible for this obstruction is in-
creased parasympathetic tone relative to sympathetic tone
due to direct α-adrenergic receptor blockade [2, 4]. Risperi-
done is a potent α1- and α2-adrenergic receptor antagonist
and therefore could potentially cause priapism [2].
Priapism may occur at any time during the treatment
course of psychotropic medications, even without a
change of dosage and even as monotherapy [2, 6]. It is
considered a serious urological emergency. It leads to ves-
sel stasis, hypoxia, ischemia, and acidosis, resulting in irre-
versible cavernosal fibrosis [2, 7]. Impotence has been
reported in more than 50 % of the cases in which priapism
was not treated [2, 7]. Treatments including ice packs, en-
emas, medications, and anesthesia generally do not pro-
duce consistent results. Management usually includes
intracavernosal washing followed by intracavernosal injec-
tion of an α-adrenergic agonist. If no α-adrenergic agonist
is effective, shunt surgery is performed between the cor-
pora cavernosa and the corpus spongiosum; otherwise,
saphenocavernosal surgery is suggested [2, 5, 7]. If the pa-
tient needs to be maintained on an antipsychotic regimen,
the dosage should be decreased or the medication should
be discontinued and replaced together with a medical
follow-up, given the high degree of risk for priapism with
antipsychotics [2, 3, 6]. Risperidone and aripiprazole are
currently the only drugs approved by the U.S. Food and
Drug Administration for the treatment of behavior prob-
lems in children with autism spectrum disorder [6]. If ap-
propriate, it is generally recommended to switch to
another antipsychotic with fewer α1-blocking properties,
such as sulpiride [8].
Conclusions
Clinicians who prescribe risperidone should be aware of
the possibility of the rare complication of priapism in
their patients. The case of our patient is of particular
interest, given both the need for prompt recognition of
this emergency and the common nonverbal and/or non-
communicative features of autism. Information about
this possible side effect and instructions regarding ap-
propriate response should be made available to care-
givers of those in the risk group of young patients.
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